60 Use of the Combined Positive Score (CPS) with the companion diagnostic PD-L1 IHC 22C3 pharmDx provides precise evaluation of PD-L1 expression across multiple tumor indications and cutoffs

60 Use of the Combined Positive Score (CPS) with the companion diagnostic PD-L1 IHC 22C3 pharmDx provides precise evaluation of PD-L1 expression across multiple tumor indications and cutoffs

Bibliographic Details
Main Authors: Jay Milo, Stephanie Hund, Angeliki Apostolaki, Siena Tabuena-Frolli, Karina Kulangara, Francisco Ponce, Lindsay Peltz, Chris La Placa, Monika Vilardo, Brittany Watts, Grant Toland, Alex Posch
Format: Article
Language:English
Published: BMJ Publishing Group 2021-11-01
Series:Journal for ImmunoTherapy of Cancer
Description
ISSN:2051-1426

Similar Items